en
Scientific article
Open access
English

Adverse events of raltegravir and dolutegravir

Published inAIDS, vol. 31, no. 13, p. 1853-1858
Publication date2017
Abstract

To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir.

Keywords
  • Adolescent
  • Adult
  • Aged
  • Aged
  • 80 and over
  • Anti-HIV Agents/administration & dosage/adverse effects
  • Drug-Related Side Effects and Adverse Reactions/epidemiology
  • Female
  • HIV Infections/drug therapy
  • Heterocyclic Compounds
  • 3-Ring/administration & dosage/adverse effects
  • Humans
  • Male
  • Mental Disorders/chemically induced/epidemiology
  • Middle Aged
  • Prospective Studies
  • Raltegravir Potassium/administration & dosage/adverse effects
  • Switzerland
  • Withholding Treatment
  • Young Adult
Research group
Citation (ISO format)
ELZI, Luigia et al. Adverse events of raltegravir and dolutegravir. In: AIDS, 2017, vol. 31, n° 13, p. 1853–1858. doi: 10.1097/QAD.0000000000001590
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0269-9370
337views
130downloads

Technical informations

Creation11/06/2018 4:39:00 PM
First validation11/06/2018 4:39:00 PM
Update time03/15/2023 3:16:59 PM
Status update03/15/2023 3:16:59 PM
Last indexation05/03/2024 6:52:05 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack